- Source type
- Government
- Access type
- Official
- Publisher
- U.S. Food and Drug Administration
- Date
- 2026-06-12
- Added
- 2026-06-27
Trust profile
94
U.S. health regulator
- Publisher type
- Regulator
- Bias profile
- Low
Best used for
- Approvals
- Labels
- Safety communications
Weak for
- Comparative effectiveness
- Consumer experience
Used in Viral Vitalism
FDA Cleared the First Over-the-Counter Glucose Monitor for Children
Roles: Regulatory status
Claims supported
No reusable evidence claims are currently attached to this source.
Related studies
No structured study record is currently attached to this source.
Related sources
About Sleep
U.S. public-health context on sleep duration, quality, disorders, and adult sleep guidance.
- Trust score
- 91
- Publisher
- Centers for Disease Control and Prevention
- Access
- Official
- Usage
- 6 connections
Dietary Guidelines for Americans, 2025–2030
Use for current U.S. dietary-guidance context and contrast with zero-plant eating patterns.
- Trust score
- 91
- Publisher
- U.S. Department of Health and Human Services / U.S. Department of Agriculture
- Access
- Official
- Usage
- 3 connections
CDC: Steps for Losing Weight
Centers for Disease Control and Prevention used across the Viral Vitalism evidence library.
- Trust score
- 91
- Publisher
- Centers for Disease Control and Prevention
- Access
- Official
- Usage
- 7 connections
Daily Value on the Nutrition and Supplement Facts Labels
Use for U.S. Nutrition Facts and Supplement Facts Daily Value context when discussing fiber, saturated fat, sodium, calcium, potassium, iodine, magnesium, and vitamins.
- Trust score
- 94
- Publisher
- U.S. Food and Drug Administration
- Access
- Official
- Usage
- 4 connections
FDA approves Wegovy for metabolic dysfunction-associated steatohepatitis with moderate-to-advanced fibrosis
U.S. Food and Drug Administration used across the Viral Vitalism evidence library.
- Trust score
- 94
- Publisher
- U.S. Food and Drug Administration
- Access
- Official
- Usage
- 6 connections
FDA: Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
Canonicalized from rapid brief compounded-glp1-shadow-market-fda-warning.
- Trust score
- 94
- Publisher
- U.S. Food and Drug Administration
- Access
- Official
- Usage
- 1 connection